InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Litton Mark James, Chairman & CEO. Insider active across 1 companies, notably Athira Pharma, Inc.. In total, 5 disclosures have been logged. The latest transaction was filed on 18 May 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
€5,103757 shares@ €6.741311.3% of flow
Common Stock
SEC:0001209191-22-039340:0·
€9,779885 shares@ €11.050148.8% of flow
Common Stock
SEC:0001209191-22-005628·
€9,779885 shares@ €11.050121.7% of flow
Common Stock
SEC:0001209191-22-005628:0·
€10,249867 shares@ €11.82151.2% of flow
Common Stock
SEC:0001209191-21-052564·
€10,249867 shares@ €11.82122.7% of flow
Common Stock
SEC:0001209191-21-052564:0·
5 of 5 declarations
About Litton Mark James
Litton Mark James is the Chairman & CEO of Athira Pharma, Inc. In this role, he is responsible for the strategic direction and management of the company's operations. His leadership is essential for guiding Athira Pharma, Inc. towards its innovation and growth objectives.
